Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q2 2024 Dermatology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q2 2024 Dermatology Update

The Dermatology sector continue to see strong deal flow, even in the face of some of the macro headwinds that have softened the broader M&A landscape. Recent transaction activity has been primarily characterized by strategic add-on acquisitions by platforms looking to build density and gain market share in existing and adjacent markets. Provident expects this theme to continue to play out throughout the rest of the year as PE-backed MSOs position for eventual sale processes of their own.

Provident anticipates multiple private equity-backed exits in Q3 and Q4, given the elongated hold periods by many private equity firms that have a platform in the space. This confluence of private equity and strategic activity should make for an active back half of the year.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/07/Q2-2024-Dermatology-vF.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]